Butterfly Network Inc., a digital health company specializing in handheld, whole-body ultrasound technology, announced that the European Commission has initiated the review and stakeholder consultation period for the company's request to revoke a specific exemption within the European Commission's Restriction of Hazardous Substances (RoHS) Directive. This exemption historically allowed the use of lead in single crystal piezoelectric materials for ultrasonic transducers. The Oeko-Institut has been appointed to conduct a technical assessment and third-party evaluation of this request. The stakeholder consultation will run from June 6, 2025, to August 1, 2025. A recommendation is expected by Q2 of 2026, with potential legal changes to follow 12 to 18 months after final adoption. Butterfly Network is optimistic about aligning ultrasound manufacturing with the EU's sustainability goals.